title: TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa.
authors.affiliation: Abimbola Farinde is a clinical supervisor in the Pharmacy Department, at Bayshore Medical Center, Pasadena, Tex.
authors.forename: Abimbola
authors.initials: A
authors.lastname: Farinde
mesh_terms: D000280:Administration, Inhalation; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications* / Q000188:drug therapy; D058995:Dry Powder Inhalers; D006801:Humans; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D014031:Tobramycin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014031:Tobramycin